These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 11920742)
1. MYCN expression in human rhabdomyosarcoma cell lines and tumour samples. Toffolatti L; Frascella E; Ninfo V; Gambini C; Forni M; Carli M; Rosolen A J Pathol; 2002 Apr; 196(4):450-8. PubMed ID: 11920742 [TBL] [Abstract][Full Text] [Related]
2. Myc oncogene expression and nude mouse tumorigenicity and metastasis formation are higher in alveolar than embryonal rhabdomyosarcoma cell lines. Kouraklis G; Triche TJ; Wesley R; Tsokos M Pediatr Res; 1999 Apr; 45(4 Pt 1):552-8. PubMed ID: 10203148 [TBL] [Abstract][Full Text] [Related]
3. Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells. Spengler BA; Lazarova DL; Ross RA; Biedler JL Oncol Res; 1997; 9(9):467-76. PubMed ID: 9495452 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors. Marampon F; Ciccarelli C; Zani BM Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113 [TBL] [Abstract][Full Text] [Related]
6. CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation. Gross N; Beretta C; Peruisseau G; Jackson D; Simmons D; Beck D Cancer Res; 1994 Aug; 54(15):4238-42. PubMed ID: 7518353 [TBL] [Abstract][Full Text] [Related]
7. Relationship between MYCN copy number and expression in rhabdomyosarcomas and correlation with adverse prognosis in the alveolar subtype. Williamson D; Lu YJ; Gordon T; Sciot R; Kelsey A; Fisher C; Poremba C; Anderson J; Pritchard-Jones K; Shipley J J Clin Oncol; 2005 Feb; 23(4):880-8. PubMed ID: 15681534 [TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid. Gee MF; Tsuchida R; Eichler-Jonsson C; Das B; Baruchel S; Malkin D Oncogene; 2005 Dec; 24(54):8025-37. PubMed ID: 16116481 [TBL] [Abstract][Full Text] [Related]
9. [Study on microtubulin of human rhabdomyosarcoma]. Ye L; Zhang HY; Bu H; Yang GH; Zhang J; Guo LX; Wang SL Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):50-3. PubMed ID: 14981814 [TBL] [Abstract][Full Text] [Related]
10. The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors. Carpentieri DF; Nichols K; Chou PM; Matthews M; Pawel B; Huff D Mod Pathol; 2002 Oct; 15(10):1080-6. PubMed ID: 12379755 [TBL] [Abstract][Full Text] [Related]
11. N-myc gene amplification in rhabdomyosarcoma detected by fluorescence in situ hybridization: its correlation with histologic features. Hachitanda Y; Toyoshima S; Akazawa K; Tsuneyoshi M Mod Pathol; 1998 Dec; 11(12):1222-7. PubMed ID: 9872655 [TBL] [Abstract][Full Text] [Related]
12. Identification of PAX3-FKHR-regulated genes differentially expressed between alveolar and embryonal rhabdomyosarcoma: focus on MYCN as a biologically relevant target. Mercado GE; Xia SJ; Zhang C; Ahn EH; Gustafson DM; Laé M; Ladanyi M; Barr FG Genes Chromosomes Cancer; 2008 Jun; 47(6):510-20. PubMed ID: 18335505 [TBL] [Abstract][Full Text] [Related]
13. [Detection of MYCN mRNA in neuroblastoma cell lines by quantitative RT-PCR]. Feng C; Tang SQ; Wang JW; Liu LZ; Gao XN; Long H Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):47-50. PubMed ID: 17306077 [TBL] [Abstract][Full Text] [Related]
14. Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas. Ferracini R; Olivero M; Di Renzo MF; Martano M; De Giovanni C; Nanni P; Basso G; Scotlandi K; Lollini PL; Comoglio PM Oncogene; 1996 Apr; 12(8):1697-705. PubMed ID: 8622890 [TBL] [Abstract][Full Text] [Related]
15. The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells. O'Brien EM; Selfe JL; Martins AS; Walters ZS; Shipley JM BMC Cancer; 2018 Feb; 18(1):217. PubMed ID: 29466962 [TBL] [Abstract][Full Text] [Related]
16. Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development. Missiaglia E; Selfe J; Hamdi M; Williamson D; Schaaf G; Fang C; Koster J; Summersgill B; Messahel B; Versteeg R; Pritchard-Jones K; Kool M; Shipley J Genes Chromosomes Cancer; 2009 Jun; 48(6):455-67. PubMed ID: 19235922 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of invasion promoting genes in childhood rhabdomyosarcoma. Armeanu-Ebinger S; Bonin M; Häbig K; Poremba C; Koscielniak E; Godzinski J; Warmann SW; Fuchs J; Seitz G Int J Oncol; 2011 Apr; 38(4):993-1000. PubMed ID: 21271214 [TBL] [Abstract][Full Text] [Related]
18. Cellular expression of adhesion factors in childhood rhabdomyosarcoma. Saxon BR; Byard RW; Han P Pediatr Pathol Lab Med; 1997; 17(2):259-66. PubMed ID: 9086532 [TBL] [Abstract][Full Text] [Related]
19. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. Chen Y; Knösel T; Kristiansen G; Pietas A; Garber ME; Matsuhashi S; Ozaki I; Petersen I J Pathol; 2003 Aug; 200(5):640-6. PubMed ID: 12898601 [TBL] [Abstract][Full Text] [Related]
20. Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes. Warnat P; Oberthuer A; Fischer M; Westermann F; Eils R; Brors B BMC Cancer; 2007 May; 7():89. PubMed ID: 17531100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]